This brand name is authorized in Croatia, Estonia, Hong Kong SAR China, Malta, Romania, Singapore, South Africa, Turkey.
The drug TETAVAX contains one active pharmaceutical ingredient (API):
1
|
UNII
K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J07AM01 | Tetanus toxoid | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AM Tetanus vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1114300, 1114311 |
| HK | Department of Health Drug Office | 57877 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-943015948 |
| MT | Medicines Authority | MA573/00402, PI770/08801A |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W58634001, W58634002, W58634003, W58634004 |
| SG | Health Sciences Authority | 13513P, 13657P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699625960107 |
| ZA | Health Products Regulatory Authority | 29/30.1/0637 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.